(Q41554170)

3 October 2017

1 reference

title

Potential involvement of type II phospholipase A2 in atherosclerosis (English)

1 reference

3 October 2017

1 reference

E Hurt-Camejo

1

1 reference

PubMed ID

9247353

3 October 2017

G Camejo

series ordinal

2

1 reference

3 October 2017

1 July 1997

1 reference

3 October 2017

1 reference

3 October 2017

132

1 reference

3 October 2017

1-8

1 reference

3 October 2017

1

1 reference

Platelet-activating factor (PAF): implications for coronary heart and vascular diseases

3 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Lysophosphatidic acid, a multifunctional phospholipid messenger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Analysis of lysophophatidylcholine-induced endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Regulation of extracellular phospholipase A2 activity: implications for inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Are events after endotoxemia related to circulating phospholipase A2?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Intracellular phospholipases A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Would the real role(s) for secretory PLA2s please stand up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Molecular modeling of protein-glycosaminoglycan interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Proteoglycans: structures and interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

The extracellular matrix and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Inhibition of human secretory class II phospholipase A2 by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Type II secretory phospholipase A2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Participation in cellular prostaglandin synthesis of type-II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

In vivo release and clearance of rat platelet phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Immunohistologic detection of non-pancreatic phospholipase A2 (type II) in human placenta and its possible involvement in normal parturition at term

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Secretory group II phospholipase A2 in human atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Human group II phospholipase A2. Characterization of monoclonal antibodies and immunochemical quantitation of the protein in synovial fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

H2O2 renders cells accessible to lysis by exogenous phospholipase A2: a novel mechanism for cell damage in inflammatory processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

The oxidant hypochlorite (OCl−), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Molecular bases of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

The mortality of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Cytokines regulate genes involved in atherogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Possible role of mammalian secretory group II phospholipase A2 in T-lymphocyte activation: implication in propagation of inflammatory reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

The response-to-retention hypothesis of early atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Effects of injury on apoB kinetics and concentration in rabbit aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Role of phospholipase A2 in expression of the scavenger pathway in cultured aortic smooth muscle cells stimulated with phorbol 12-myristate 13-acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Beyond LDL cholesterol reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Alterations in the physiochemical characteristics of low and high density lipoproteins after lipolysis with phospholipase A2. A spin-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Enhanced binding of phospholipase-A2-modified low density lipoprotein by human adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

Phospholipase A2-modified LDL is taken up at enhanced rate by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900085-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(97)00085-3

1 reference

3 October 2017

1 reference

PubMed ID

9247353